Dr. Grazia Aleppo is a professor of medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Feinberg School of Medicine, Northwestern University, Chicago. She is also the associate chief for Clinical Affairs in the same Division and the Medical Director of the Northwestern Medicine Diabetes Training and Education Program.
Dr Aleppo’s clinical interest and research interests are in diabetes, particularly in the implementation of diabetes technology, insulin pump therapy, continuous glucose monitoring (CGM) therapy and automated insulin delivery in clinical practice. She has participated in major clinical trials on the use of CGM in various populations and was the protocol chair for the Replace-BG clinical trial which lead to the approval of CGM therapy for Medicare beneficiaries in the U.S.
